Therapeutic use of anti-CS1 antibodies
- Application ID: EP14178061
- Status: █ The patent has been granted
This EP application has the IPC class A61, C07, and C12. J A Kemp is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 134 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.